Qiang Lu

1PUBLICATIONS
0CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Mar 26, 2019
Nimotuzumab inhibits epithelial-mesenchymal transition in prostate cancer by targeting the Akt/YB-1/AR axis.

Sheng Hu, Yi-Xing Duan, Qiang Zhou

Pageof 1

Frequent Collaborators